AbCellera, a biotechnology firm headquartered in Vancouver, has announced its participation in upcoming investor conferences scheduled for November 2026. The company will present at the Stifel Healthcare Conference on November 11, 2026, followed by the Jefferies Global Healthcare Conference in London on November 16, 2026. Investors and interested stakeholders will be able to listen to the presentations through a live audio webcast. The details and access information for the webcast will be made available on AbCellera’s Investor Relations website ahead of the events. The conferences serve as a platform for the company to engage with investors and discuss its ongoing projects and developments in the biotechnology sector.
Analyzed Canadian Outlets (1)
1 headline